388 related articles for article (PubMed ID: 26804029)
21. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
[TBL] [Abstract][Full Text] [Related]
22. Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss.
Alam G; Edler M; Burchfield S; Richardson JR
Neurotoxicology; 2017 May; 60():99-106. PubMed ID: 28377118
[TBL] [Abstract][Full Text] [Related]
23. Nociceptin/orphanin FQ and opioid receptor-like receptor mRNA expression in dopamine systems.
Norton CS; Neal CR; Kumar S; Akil H; Watson SJ
J Comp Neurol; 2002 Mar; 444(4):358-68. PubMed ID: 11891648
[TBL] [Abstract][Full Text] [Related]
24. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
25. Post-blast treatment with Nociceptin/Orphanin FQ peptide (NOP) receptor antagonist reduces brain injury-induced hypoxia and signaling proteins in vestibulomotor-related brain regions.
Awwad HO; Durand CD; Gonzalez LP; Tompkins P; Zhang Y; Lerner MR; Brackett DJ; Sherry DM; Awasthi V; Standifer KM
Behav Brain Res; 2018 Mar; 340():183-194. PubMed ID: 27793733
[TBL] [Abstract][Full Text] [Related]
26. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
[TBL] [Abstract][Full Text] [Related]
27. The TrkB-positive dopaminergic neurons are less sensitive to MPTP insult in the substantia nigra of adult C57/BL mice.
Ding YX; Xia Y; Jiao XY; Duan L; Yu J; Wang X; Chen LW
Neurochem Res; 2011 Oct; 36(10):1759-66. PubMed ID: 21562748
[TBL] [Abstract][Full Text] [Related]
28. Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
Hayley S; Crocker SJ; Smith PD; Shree T; Jackson-Lewis V; Przedborski S; Mount M; Slack R; Anisman H; Park DS
J Neurosci; 2004 Feb; 24(8):2045-53. PubMed ID: 14985447
[TBL] [Abstract][Full Text] [Related]
29. Role of nociceptin/orphanin FQ and NOP receptors in the response to acute and repeated restraint stress in rats.
Delaney G; Dawe KL; Hogan R; Hunjan T; Roper J; Hazell G; Lolait SJ; Fulford AJ
J Neuroendocrinol; 2012 Dec; 24(12):1527-41. PubMed ID: 22835008
[TBL] [Abstract][Full Text] [Related]
30. Dual motor response to l-dopa and nociceptin/orphanin FQ receptor antagonists in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) treated mice: Paradoxical inhibition is relieved by D(2)/D(3) receptor blockade.
Viaro R; Marti M; Morari M
Exp Neurol; 2010 Jun; 223(2):473-84. PubMed ID: 20122926
[TBL] [Abstract][Full Text] [Related]
31. Exploring LPS-induced sepsis in rats and mice as a model to study potential protective effects of the nociceptin/orphanin FQ system.
Thomas RC; Bath MF; Stover CM; Lambert DG; Thompson JP
Peptides; 2014 Nov; 61():56-60. PubMed ID: 25161013
[TBL] [Abstract][Full Text] [Related]
32. Expression of peroxisome proliferator-activated receptor-gamma in the substantia nigra of hemiparkinsonian nonhuman primates.
Swanson C; Emborg M
Neurol Res; 2014 Jul; 36(7):634-46. PubMed ID: 24620964
[TBL] [Abstract][Full Text] [Related]
33. The nociceptin/orphanin FQ receptor antagonist J-113397 and L-DOPA additively attenuate experimental parkinsonism through overinhibition of the nigrothalamic pathway.
Marti M; Trapella C; Viaro R; Morari M
J Neurosci; 2007 Feb; 27(6):1297-307. PubMed ID: 17287504
[TBL] [Abstract][Full Text] [Related]
34. Further evidence for an involvement of nociceptin/orphanin FQ in the pathophysiology of Parkinson's disease: a behavioral and neurochemical study in reserpinized mice.
Volta M; Mabrouk OS; Bido S; Marti M; Morari M
J Neurochem; 2010 Dec; 115(6):1543-55. PubMed ID: 20950413
[TBL] [Abstract][Full Text] [Related]
35. Fear expression is reduced after acute and repeated nociceptin/orphanin FQ (NOP) receptor antagonism in rats: therapeutic implications for traumatic stress exposure.
Taylor RM; Jeong IH; May MD; Bergman EM; Capaldi VF; Moore NLT; Matson LM; Lowery-Gionta EG
Psychopharmacology (Berl); 2020 Oct; 237(10):2943-2958. PubMed ID: 32588078
[TBL] [Abstract][Full Text] [Related]
36. Nociceptin/orphanin FQ inhibition with SB612111 ameliorates dextran sodium sulfate-induced colitis.
Alt C; Lam JS; Harrison MT; Kershaw KM; Samuelsson S; Toll L; D'Andrea A
Eur J Pharmacol; 2012 May; 683(1-3):285-93. PubMed ID: 22449384
[TBL] [Abstract][Full Text] [Related]
37. Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice.
Schlüter OM; Fornai F; Alessandrí MG; Takamori S; Geppert M; Jahn R; Südhof TC
Neuroscience; 2003; 118(4):985-1002. PubMed ID: 12732244
[TBL] [Abstract][Full Text] [Related]
38. Retrodialysis of N/OFQ into the nucleus accumbens shell blocks cocaine-induced increases in extracellular dopamine and locomotor activity.
Vazquez-DeRose J; Stauber G; Khroyan TV; Xie XS; Zaveri NT; Toll L
Eur J Pharmacol; 2013 Jan; 699(1-3):200-6. PubMed ID: 23219985
[TBL] [Abstract][Full Text] [Related]
39. Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease.
Anandhan A; Tamilselvam K; Radhiga T; Rao S; Essa MM; Manivasagam T
Brain Res; 2012 Jan; 1433():104-13. PubMed ID: 22138428
[TBL] [Abstract][Full Text] [Related]
40. NOP Receptor Antagonists Decrease Alcohol Drinking in the Dark in C57BL/6J Mice.
Brunori G; Weger M; Schoch J; Targowska-Duda K; Barnes M; Borruto AM; Rorick-Kehn LM; Zaveri NT; Pintar JE; Ciccocioppo R; Toll L; Cippitelli A
Alcohol Clin Exp Res; 2019 Oct; 43(10):2167-2178. PubMed ID: 31386211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]